Phase 2 Study of YS110, a Recombinant Humanized Anti-CD26 Monoclonal Antibody, in Japanese Patients With Advanced Malignant Pleural Mesothelioma
一项针对日本晚期恶性胸膜间皮瘤患者的YS110(一种重组人源化抗CD26单克隆抗体)的II期研究
期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2021.100178
Nakagawa, Kazuhiko; Kijima, Takashi; Okada, Morihito; Morise, Masahiro; Kato, Motoyasu; Hirano, Katsuya; Fujimoto, Nobukazu; Takenoyama, Mitsuhiro; Yokouchi, Hiroshi; Ohe, Yuichiro; Hida, Toyoaki; Aoe, Keisuke; Kishimoto, Takumi; Hirokawa, Masato; Matsuki, Hironori; Kaneko, Yutaro; Yamada, Taketo; Morimoto, Chikao; Takeda, Masayuki